In the context of ICI treatment, a cellular triad composed of mregDCs, CXCL13+ helper T (Th) cells, and PD-1hi progenitor CD8+ T cells is significantly enriched in the HCC microenvironment. This evidence concerns the gene CD8A and hepatocellular carcinoma.